Nataraj Pagadala - molecular glues for targeted protein degradation

Nataraj Pagadala, founder, president, and CEO of LigronBio, discusses his company's goal of using molecular glues to target traditionally undruggable proteins as a route to new therapies for neurodegenerative diseases. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics. https://www.bioinformaticscro.com/